Entomopathogenic fungi are ubiquitous in tropical rainforests and function a excessive stage of range. This group of fungi not solely has necessary ecological worth but in addition medicinal worth. Nevertheless, they’re typically ignored, and many unknown species have but to be found and described. The current examine goals to contribute to the taxonomical and phylogenetic understanding of the genus Paraisaria by describing three new species collected from Guizhou and Yunnan Provinces in China and Krabi Province in Thailand.
The three novel species named Paraisaria alba, P. arcta, and P. rosea share comparable morphologies as these within the genus Paraisaria, containing solitary, easy, fleshy stroma, fully immersed perithecia and cylindrical asci with thickened caps and filiform ascospores that usually disarticulate at maturity. Phylogenetic analyses of mixed LSU, SSU, TEF1-α, RPB1, RPB2, and ITS sequence knowledge verify their placement within the genus Paraisaria. In this examine, the three entomopathogenic taxa are comprehensively described with colour images and phylogenetic analyses. A synopsis desk and a key to all handled species of Paraisaria are additionally included.
First report of alfalfa leaf spot brought on by Leptosphaerulina australis in China
A illness was noticed on alfalfa cultivar WL168 characterised by white to brown leaf spots of normal to spherical shapes, in Aluhorqin County, Inner Mongolia, China (120°13’23″ to 120°29’14″ E, 43°27’52″to 43°35’16″ N, 281.71m to360.13 m Altitude) throughout 2019 to 2020. The illness primarily offered in spring one month after re-greening and the incidence was 78.30% on this discipline.
Twenty alfalfa vegetation with extreme signs had been used for pathogen isolation. The contaminated tissue was reduce into 2 × 2 mm items, surface-sterilized (in 75% ethanol and 5% business bleach (NaClO) for 30 s and 2 min, respectively), rinsed 5 occasions with sterilized distilled water, and dried between sterile filter paper (Wang et al. 2019). The diseased tissue from every plant pattern had been cultured on potato dextrose agar (PDA) and incubated at 25 °C with 12 h mild/day for ten days.
A fungus was remoted from the diseased leaves at a 100% frequency. Fungal development on PDA was spherical with a black floor, radial edge, and a unclean white middle. The ascocarps had been moved to a clear microscope slide to launch asci and ascospores. Ascocarps had been spheroidal, subglobose brown, 120 to 160 µm × 160 to 180 µm, which include a number of ascus. The dimension of ascus had been 31.zero to 41.6 μm × 75.zero to 87.5 μm and every asci having eight ascospores.
Ascospores had been ellipsoid to rectangular with a gelatinous sheath, brown, 8.Eight to 15.zero µm × 29.9 to 43.zero µm with 2 to three horizontal septums, and zero to 2 vertical septums. A phylogenetic tree was constructed after DNA extraction, PCR with primers to amplify the ITS (VG9: 5′- TTACGTCCCTGCCCTTTGTA-3′ and ITS4: 5′-TCCTCCGCTTATTGATATGC-3′) and LSU (LR7: 5′-TACTACCACCAAGATCT-3′ and LROR: 5′- GTACCCGCTGA ACTTAAGC -3′) areas. The LSU (SUB8273071) and ITS (SUB8218291) amplicons confirmed 99% similarity with L. australis (EU754166.1) within the GenBank.
To confirm the pathogenicity, fungs plugs had been inverted on three compound leaves of 20 alfalfa WL168 for 2 days. Agar plugs (PDA) had been inverted on one other 20 alfalfa WL168 three compound leaves which had been management. All vegetation had been maintained at 22 °C and 44% relative humidity in a development chamber. Similar illness signs had been noticed on contaminated leaves ten days after inoculation, whereas management vegetation confirmed no signs.
The similar fungus was re-isolated from the lesions, and additional morphological characterization and molecular assays, as described above. L. australis has been reported on numerous vegetation, together with Prunusarmeniaca, Dolichos, Poa, Lolium, and Vitis in Australia (Graham and Luttrell., 1961), and additionally from Korean soil in 2018 (Weilan et al., 2018). Additionally, L. briosiana, which is frequent within the USA, China, and different nations, causes Leptosphaerulina leaf spot (Samacet al., 2015). L. trifolii is newly reported to happen in China (Liu et al., 2019). To one of the best of our information, that is the primary report of L. australis infecting alfalfa in China. Considering the big planting space in Inner Mongolia, this pathogen might losses to alfalfa cultivation. Hence, future research ought to discover points of efficient administration of this illness.
Four new species of Talaromyces part Talaromyces found in China
Four new Talaromyces species with none shut kinfolk are reported right here, specifically, T. aureolinus (ex-type AS3.15865 T), T. bannicus (ex-type AS3.15862 T), T. penicillioides (ex-type AS3.15822 T), and T. sparsus (ex-type AS3.16003 T). Morphologically, T. aureolinus is exclusive in producing orange-yellow mycelium and gymnothecia, singly borne asci, and ellipsoidal, spiny ascospores.
Talaromyces bannicus is characterised by the sluggish development price, polymorphic conidiophores, inconsistent stipe lengths, and pyriform to ellipsoidal, echinulate conidia. Talaromyces penicillioides is distinguished by good development and sporulation on malt extract agar (MEA) and yeast extract sucrose agar (YES) media, resembling the colony appearances of sure Penicillium species, and appressed biverticillate and sometimes monoverticillate penicilli bearing globose to ellipsoidal, echinulate conidia.
FSCN1 Antibody |
1-CSB-PA009010GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against FSCN1. Recognizes FSCN1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
FSCN1 Antibody |
1-CSB-PA005142 |
Cusabio |
|
|
|
Description: A polyclonal antibody against FSCN1. Recognizes FSCN1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
FSCN1 Antibody |
35636-100ul |
SAB |
100ul |
EUR 252 |
FSCN1 Monoclonal Antibody |
A1062-50 |
Biovision |
|
EUR 300 |
Fascin (FSCN1) Antibody |
20-abx126914 |
Abbexa |
|
|
|
Fascin (Fscn1) Antibody |
20-abx112474 |
Abbexa |
|
|
|
Fascin (FSCN1) Antibody |
20-abx006708 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
|
Fascin (FSCN1) Antibody |
abx032965-400ul |
Abbexa |
400 ul |
EUR 523 |
|
Fascin (FSCN1) Antibody |
abx032965-80l |
Abbexa |
80 µl |
EUR 286 |
|
Fascin (FSCN1) Antibody |
abx432714-200ul |
Abbexa |
200 ul |
EUR 384 |
|
Fascin (FSCN1) Antibody |
20-abx338423 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
Fascin (FSCN1) Antibody |
20-abx241222 |
Abbexa |
|
|
|
Fascin (FSCN1) Antibody |
20-abx214267 |
Abbexa |
|
|
|
Fascin (FSCN1) Antibody |
abx233018-100ug |
Abbexa |
100 ug |
EUR 551 |
|
Fascin (FSCN1) Antibody |
20-abx141208 |
Abbexa |
-
EUR 356.00
-
EUR 537.00
-
EUR 217.00
|
|
|
Anti-FSCN1 antibody |
STJ27695 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene encodes a member of the fascin family of actin-binding proteins. Fascin proteins organize F-actin into parallel bundles, and are required for the formation of actin-based cellular protrusions. The encoded protein plays a critical role in cell migration, motility, adhesion and cellular interactions. Expression of this gene is known to be regulated by several microRNAs, and overexpression of this gene may play a role in the metastasis of multiple types of cancer by increasing cell motility. Expression of this gene is also a marker for Reed-Sternberg cells in Hodgkin's lymphoma. A pseudogene of this gene is located on the long arm of chromosome 15. |
Anti-FSCN1 antibody |
STJ23712 |
St John's Laboratory |
100 µl |
EUR 413 |
Description: This gene encodes a member of the fascin family of actin-binding proteins. Fascin proteins organize F-actin into parallel bundles, and are required for the formation of actin-based cellular protrusions. The encoded protein plays a critical role in cell migration, motility, adhesion and cellular interactions. Expression of this gene is known to be regulated by several microRNAs, and overexpression of this gene may play a role in the metastasis of multiple types of cancer by increasing cell motility. Expression of this gene is also a marker for Reed-Sternberg cells in Hodgkin's lymphoma. A pseudogene of this gene is located on the long arm of chromosome 15. |
Fascin (FSCN1) Antibody |
20-abx327559 |
Abbexa |
|
|
|
Anti-FSCN1 antibody |
STJ115318 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene encodes a member of the fascin family of actin-binding proteins. Fascin proteins organize F-actin into parallel bundles, and are required for the formation of actin-based cellular protrusions. The encoded protein plays a critical role in cell migration, motility, adhesion and cellular interactions. Expression of this gene is known to be regulated by several microRNAs, and overexpression of this gene may play a role in the metastasis of multiple types of cancer by increasing cell motility. Expression of this gene is also a marker for Reed-Sternberg cells in Hodgkin's lymphoma. A pseudogene of this gene is located on the long arm of chromosome 15. |
FSCN1 Conjugated Antibody |
C35636 |
SAB |
100ul |
EUR 397 |
FSCN1 siRNA |
20-abx917244 |
Abbexa |
|
|
|
FSCN1 siRNA |
20-abx917245 |
Abbexa |
|
|
|
FSCN1 siRNA |
20-abx902015 |
Abbexa |
|
|
|
FSCN1 Antibody, HRP conjugated |
1-CSB-PA619084LB01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against FSCN1. Recognizes FSCN1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
FSCN1 Antibody, FITC conjugated |
1-CSB-PA619084LC01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against FSCN1. Recognizes FSCN1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
FSCN1 Antibody, Biotin conjugated |
1-CSB-PA619084LD01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against FSCN1. Recognizes FSCN1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Anti-Fascin/FSCN1 Antibody |
PA1575 |
BosterBio |
100ug/vial |
EUR 294 |
Anti-Fascin/FSCN1 Antibody |
PB9592 |
BosterBio |
100ug/vial |
EUR 294 |
Fascin (FSCN1) Antibody (HRP) |
20-abx335658 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
Fascin (FSCN1) Antibody (FITC) |
20-abx335659 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
Fascin (FSCN1) Antibody (Biotin) |
20-abx335660 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
FSCN1 Polyclonal Conjugated Antibody |
C30401 |
SAB |
100ul |
EUR 397 |
Fscn1 Blocking Peptide |
33R-9865 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Fscn1 antibody, catalog no. 70R-8641 |
FSCN1 Blocking Peptide |
DF7988-BP |
Affbiotech |
1mg |
EUR 195 |
FSCN1 cloning plasmid |
CSB-CL619084HU-10ug |
Cusabio |
10ug |
EUR 524 |
|
Description: A cloning plasmid for the FSCN1 gene. |
FSCN1 Rabbit pAb |
A5867-100ul |
Abclonal |
100 ul |
EUR 308 |
FSCN1 Rabbit pAb |
A5867-200ul |
Abclonal |
200 ul |
EUR 459 |
FSCN1 Rabbit pAb |
A5867-20ul |
Abclonal |
20 ul |
Ask for price |
FSCN1 Rabbit pAb |
A5867-50ul |
Abclonal |
50 ul |
Ask for price |
FSCN1 Rabbit pAb |
A13355-100ul |
Abclonal |
100 ul |
EUR 308 |
FSCN1 Rabbit pAb |
A13355-200ul |
Abclonal |
200 ul |
EUR 459 |
FSCN1 Rabbit pAb |
A13355-20ul |
Abclonal |
20 ul |
EUR 183 |
FSCN1 Rabbit pAb |
A13355-50ul |
Abclonal |
50 ul |
EUR 223 |
Fascin-1(FSCN1/416) Antibody |
BNCA0416-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/416), APC conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCA0417-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/417), APC conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCA0418-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/418), APC conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNCAP0416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNCAP0416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCAP0417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCAP0417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCAP0418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCAP0418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC810416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC810416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC810417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC810417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC810418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC810418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF680R conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC880416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC880416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC880417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC880417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC880418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC880418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF488A conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNCB0416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNCB0416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCB0417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCB0417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCB0418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCB0418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), Biotin conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC550416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC550416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC550417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC550417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC550418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC550418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF555 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC430416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC430416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC430417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC430417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC430418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC430418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF543 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC470416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC470416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC470417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC470417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC470418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC470418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF647 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC940416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC940416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC940417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC940417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC940418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC940418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF594 conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNCP0416-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/416), PerCP conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCP0417-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/417), PerCP conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNCP0418-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/418), PerCP conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC040416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC040416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC040417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC040417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC040418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC040418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF405S conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC050416-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF405M conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/416) Antibody |
BNC050416-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/416), CF405M conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC050417-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF405M conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNC050417-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/417), CF405M conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC050418-100 |
Biotium |
100uL |
EUR 199 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF405M conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/418) Antibody |
BNC050418-500 |
Biotium |
500uL |
EUR 544 |
Description: Primary antibody against Fascin-1(FSCN1/418), CF405M conjugate, Concentration: 0.1mg/mL |
Polyclonal FSCN1 Antibody (internal region) |
APR16037G |
Leading Biology |
0.1 mg |
EUR 484 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human FSCN1 (internal region). This antibody is tested and proven to work in the following applications: |
[KO Validated] FSCN1 Polyclonal Antibody |
30401-100ul |
SAB |
100ul |
EUR 252 |
[KO Validated] FSCN1 Polyclonal Antibody |
30401-50ul |
SAB |
50ul |
EUR 187 |
Fascin-1(FSCN1/416) Antibody |
BNCR0416-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/416), RPE conjugate, Concentration: 0.1mg/mL |
Fascin-1(FSCN1/417) Antibody |
BNCR0417-250 |
Biotium |
250uL |
EUR 383 |
Description: Primary antibody against Fascin-1(FSCN1/417), RPE conjugate, Concentration: 0.1mg/mL |
Talaromyces sparsus has extensive, submerged colony margins with sparse aerial mycelium, and conidial areas overlaid with yellow-green, sterile hyphae on MEA medium. These 4 new species are effectively supported by particular person phylogenetic timber based mostly on β-tubulin (BENA), calmodulin (CALM), DNA-dependent RNA polymerase II second largest subunit (RPB2), and inside transcribed spacer area (ITS) gene sequences and the tree of the concatenated BENA-CALM-RPB2 sequence.